Basilea Pharmaceutica AG BPMUF:OTCPK

RT Quote | Exchange | USD
Last | 02/19/21 EST
57.99UNCH (UNCH)
52 week range
36.95 - 61.00

...

Loading . . .

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close57.99
  • 52 Week High61.00
  • 52 Week High Date02/17/21
  • 52 Week Low36.95
  • 52 Week Low Date03/25/20
  • Market Cap623.82M
  • Shares Out10.87M
  • 10 Day Average Volume100
  • Dividend-
  • Dividend Yield-
  • Beta0.11
  • 1 Year % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-1.81
  • P/E (TTM)-32.03
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Basilea Pharmaceutica AG News

QUOTE FINDER

Profile

MORE
Basilea Pharmaceutica AG is a Switzerland-based company engaged in the research, development and commercialization of pharmaceutical products. The Company focuses on pharmaceutical products in the therapeutic areas of bacterial infections, fungal infections and oncology. The Company has a range of drugs to treat drug-resistant bacterial infections, systemic fungal infections and drug-resistant tumors. The Company’s anti-infectives, including isavuconazole and ceftobiprole are...
Domenico Scala
Chairman
Thomas Werner Ph.D.
Vice Chairman
David Veitch
Chief Executive Officer
Adesh Kaul
Chief Financial Officer
Gerrit Hauck Ph.D.
Chief Technology Officer
Damian Heller
General Counsel
Address
Grenzacherstrasse 487
Basel
4058
Switzerland